Combivir
Company: GlaxoWellcome
Approval Status: Approved September 1997
Treatment for: AIDS, HIV Infection
Areas: Immunology/Infectious Diseases
| General Information | Side Effects |
General Information
Other Useful Resources
The U.S. Food and Drug Administration approved the first one-pill combination of the two most widely used antiretroviral medications for AIDS and HIV infection. Combivir, a combination of Retrovir (zidovudine or AZT) and Epivir (lamivudine or 3TC), could decrease the number of pills people with HIV have to take daily.
Side Effects
Side effects include: nausea, diarrhea, anemia, low white blood cells, pancreatitis and neuropathy.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
